Borrelia p30

Borrelia Burgdorferi p30 Recombinant
Cat. No.
BT29610
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Borrelia Burgdorferi p30 Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain having a molecular mass of 29kDa. Borrelia p30 is expressed with a 6xHis tag and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Borrelia is a genus of bacteria in the spirochete phylum. These bacteria are responsible for causing borreliosis, a zoonotic vector-borne disease primarily transmitted through tick bites and occasionally through lice, depending on the specific species. Among the 36 identified Borrelia species, 12 are known to cause Lyme disease or borreliosis and are spread by ticks. Borreliella spielmanii, a Gram-negative bacterium, is one of the pathogens within the Borreliella burgdorferi sensu lato complex that causes Lyme disease. DbpA, also referred to as p17 or Osp17, exhibits variation among the human pathogenic B. burgdorferi sensu lato species.
Description
Recombinant Borrelia Burgdorferi p30, produced in E. coli, is a single, non-glycosylated polypeptide chain with a molecular weight of 29kDa. It is expressed with a 6xHis tag and purified using proprietary chromatographic methods.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
Borrelia p30 is supplied in a buffer solution of 20mM HEPES (pH 7.5), 400mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze at -20°C. Repeated freezing and thawing should be avoided.
Purity
Purity is determined to be greater than 80.0% using SDS-PAGE analysis.
Applications
This product is suitable for Western blot analysis using Lyme disease-positive plasma samples.
Immunological Functions
This protein exhibits the following immunological functions: 1. It binds to both IgG and IgM human antibodies. 2. It can be utilized in immunodot tests for differentiating between Lyme disease-positive and -negative samples.
Source
Escherichia Coli.

Product Science Overview

Introduction

Borrelia burgdorferi is a spirochete bacterium responsible for Lyme disease, a zoonotic, vector-borne disease primarily transmitted by ticks . Among the various proteins expressed by Borrelia burgdorferi, the p30 protein has garnered significant attention due to its role in the bacterium’s pathogenicity and its potential use in diagnostic assays .

Borrelia Burgdorferi p30 Protein

The p30 protein, also known as OspA (Outer surface protein A), is a major surface protein of Borrelia burgdorferi. It plays a crucial role in the bacterium’s ability to infect and persist within its host. The recombinant form of this protein, Borrelia burgdorferi p30 recombinant, is produced in Escherichia coli (E. coli) and is used in various research and diagnostic applications .

Production and Purification

Borrelia burgdorferi p30 recombinant is produced as a single, non-glycosylated polypeptide chain with a molecular mass of approximately 29 kDa . The protein is expressed with a 6xHis tag, which facilitates its purification through affinity chromatography techniques. The purified protein is typically supplied in a sterile, filtered solution containing HEPES buffer, NaCl, and glycerol to ensure stability and prevent degradation .

Applications

The recombinant p30 protein is widely used in laboratory research, particularly in the development of diagnostic assays for Lyme disease. Some of its key applications include:

  1. Western Blotting: The p30 protein is used as an antigen in Western blot assays to detect IgG and IgM antibodies in patient sera. This helps in the diagnosis of Lyme disease by identifying specific immune responses to Borrelia burgdorferi .
  2. Immunodot Tests: The protein is also employed in immunodot tests, which are used to differentiate between Lyme disease-positive and -negative samples .
  3. Research Studies: Researchers use the recombinant p30 protein to study the immune response to Borrelia burgdorferi and to develop new diagnostic and therapeutic approaches for Lyme disease .
Stability and Storage

To maintain its stability, the recombinant p30 protein should be stored at 4°C if it is to be used within 2-4 weeks. For longer storage periods, it should be kept frozen at -20°C. It is important to avoid multiple freeze-thaw cycles to prevent protein degradation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.